基本信息
浏览量:522
职业迁徙
个人简介
He is internationally recognized as a leader in the development of novel proteomics methods and in their application in biology, chemistry, and medicine.
Carr and his group of staff scientists and postdoctoral fellows collaborate with scientists throughout the Broad Institute community (comprised of MIT, Harvard University Faculty of Arts and Sciences, Harvard Medical School, and the 17 Harvard-affiliated hospitals) to apply state-of-the-art proteomics technology to address compelling questions in biology, chemistry, and clinical medicine.
Research in his laboratory focuses on developing and applying new technologies to quantify proteins and their modifications and interaction partners in tissues, cells, and biofluids with high sensitivity and specificity; improving informatics for peptide and protein assignment using mass spectrometry (MS) data; and integration of MS-derived data with genomic data to understand disease biology and drug effects. The group also has a major focus on the discovery and quantitative verification of biomarkers for major diseases including cancer and cardiovascular and infectious diseases, as well as pharmacodynamics markers of drug response.
Carr and his group of staff scientists and postdoctoral fellows collaborate with scientists throughout the Broad Institute community (comprised of MIT, Harvard University Faculty of Arts and Sciences, Harvard Medical School, and the 17 Harvard-affiliated hospitals) to apply state-of-the-art proteomics technology to address compelling questions in biology, chemistry, and clinical medicine.
Research in his laboratory focuses on developing and applying new technologies to quantify proteins and their modifications and interaction partners in tissues, cells, and biofluids with high sensitivity and specificity; improving informatics for peptide and protein assignment using mass spectrometry (MS) data; and integration of MS-derived data with genomic data to understand disease biology and drug effects. The group also has a major focus on the discovery and quantitative verification of biomarkers for major diseases including cancer and cardiovascular and infectious diseases, as well as pharmacodynamics markers of drug response.
研究兴趣
论文共 396 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Ronald Cutler,Laura Corveleyn,Claudia Ctortecka, Joshua Cantlon, Sebastian Alvaro Jacome Vaca,Dieter Deforce,Jan Vijg,Maarten Dhaenens,Malvina Papanastasiou,Steven A. Carr,Simone Sidoli
biorxiv(2024)
Claudia Ctortecka,Natalie M Clark, Brian W Boyle,Anjali Seth,D R Mani,Namrata D Udeshi,Steven A Carr
Nature communicationsno. 1 (2024): 5707-5707
CELL REPORTSno. 1 (2024): 113596-113596
Communications biologyno. 1 (2024): 87-87
Mariska Simpson,Heidi De Luca, Sarah Cauthorn,Phi Luong,Namrata Udeshi,Tanya Svinkina, Stefanie Schmeider,Steven Carr,Michael Grey,Wayne Lencer
bioRxiv (Cold Spring Harbor Laboratory)no. 12 (2023)
引用0浏览0引用
0
0
crossref(2023)
Molecular & Cellular Proteomicsno. 6 (2023): 100563-100563
Human molecular geneticsno. 1 (2023): 30-45
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn